Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei - Potential implication for arousal and attention

Neuroscience

Volumn 104, Issue 3, 2001, Pages 643-652

  Sauvage, M ^a   Steckler, T ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Basal forebrain; Brainstem; Choline acetyltransferase; Corticotropin releasing hormone receptor 1; Immunoreactivity; Tyrosine hydroxylase

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; ATTENTION; BRAIN STEM; CARBOXY TERMINAL SEQUENCE; CATECHOLAMINERGIC SYSTEM; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; DOPAMINERGIC NERVE CELL; FOREBRAIN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LOCUS CERULEUS; MALE; MOUSE; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; SUBSTANTIA INNOMINATA; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ACETYLCHOLINE; ANIMALS; AROUSAL; ATTENTION; BASAL NUCLEUS OF MEYNERT; BRAIN STEM; CHOLINE O-ACETYLTRANSFERASE; DOPAMINE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NEURONS; NOREPINEPHRINE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TYROSINE 3-MONOOXYGENASE;

EID: 0035859205     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00137-3     Document Type: Article

References (62)

1. Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal
2. Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: A topographical study
3. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder
4. Genetically determined cholinergic deficiency in the forebrain of C57BL/6 mice
5. Immunoaffinity purification of human choline acetyltransferase: Comparison of the brain and placental enzymes
6. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus
7. Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal
8. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression
9. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: Light microscopy analysis using an antibody directed against the C-terminus
10. Dissociable effects of lesions to the dorsal or ventral noradrenergic bundle on the acquisition, performance, and extinction of aversive conditioning
11. Forebrain norepinephrine: Role in controlled information processing in the rat
12. Corticotropin-releasing factor neurotransmission in locus coeruleus: A possible site of antidepressant action
13. Prenatal stress enhances stress- and corticotrophin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats
14. Corticotropin-releasing factor administered centrally, but not peripherally, stimulates hippocampal acetylcholine release
15. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
16. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
17. Cloning and characterization of human urocortin
18. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses?
19. 2-Methyl-1,2,3,4-tetrahydroisoquinoline does dependently reduce the number of tyrosine hydroxylase-immunoreactive cells in the substantia nigra and locus ceruleus of C57BL/6J mice
20. The pedunculopontine nucleus
21. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex
22. The psychobiological basis of posttraumatic stress disorder
23. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior
24. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
25. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
26. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain
27. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis
28. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain
29. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats
30. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues
31. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
32. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala
33. Dissociable effects of AMPA-induced lesions of the vertical limb diagonal band of Broca on performance of the 5-choice serial reaction time task and on acquisition of a conditional visual discrimination
34. Attentional functions of the forebrain cholinergic systems: Effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task
35. AMPA-induced excitotoxic lesions of the basal forebrain: A significant role for the cortical cholinergic system in attentional function
36. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001
37. Effects of CRH and LHRH on rat septo-hippocampal neurons
38. Physiology and pharmacology of corticotropin-releasing factor
39. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: Implications for a role for CRF in the pathogenesis of anxiety disorders
40. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task
41. Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system
42. Role of norepinephrine in the pathophysiology and treatment of mood disorders
43. Arousal systems and attentional processes
44. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: Further implications for the role of the cholinergic neurons in the nucleus basalis in cognitive processes
45. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain
46. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents
47. CP-154, 526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
48. Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety
49. CRF receptor antagonist attenuates immobilization stress-induced norepinephrine release in the prefrontal cortex in rats
50. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
51. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder
52. Corticotropin-releasing hormone receptor subtypes and emotion
53. The pedunculopontine tegmental nucleus: A role in cognitive processes?
54. The noradrenergic system in pathological anxiety: A focus on panic with relevance to generalized anxiety and phobias
55. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
56. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
57. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses
58. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain
59. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse
60. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
61. Cholinergic and non-cholinergic projections from the rat basal forebrain revealed by combined choline acetyltransferase and Phaseolus vulgaris leucoagglutinin immunohistochemistry